Ruiqi Wang

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients.

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients.

Journal: Translational oncology
Published: June 27, 2025

Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC.

Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 25, 2025

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma.

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma.

Journal: Scientific reports
Published: February 06, 2025

Targeting CD38 with Daratumumab in a Newly Diagnosed Case of POEMS Syndrome with a 17p Deletion in a Solitary Plasmacytoma of the Bone: A Case Study and Literature Review.

Targeting CD38 with Daratumumab in a Newly Diagnosed Case of POEMS Syndrome with a 17p Deletion in a Solitary Plasmacytoma of the Bone: A Case Study and Literature Review.

Journal: Neurology India
Published: November 07, 2024

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation.

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation.

Journal: Scientific reports
Published: August 18, 2024

BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL.

BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL.

Journal: Annals of hematology
Published: February 18, 2024

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review.

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review.

Journal: Frontiers in pharmacology
Published: April 17, 2023

Metastatic germ cell tumor showing a durable response to the anti-PD-1 antibody toripalimab.

Metastatic germ cell tumor showing a durable response to the anti-PD-1 antibody toripalimab.

Journal: Immunotherapy
Published: April 06, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026